Fundamentals in Urology: Online Pathology and Urodynamics Modules (2018)

This year's course features enhanced programming that allows registrants to access additional online learning resources and modules at the convenience of their home for less time away from the office! The Online Pathology and Urodynamics Modules will include the following content:

  • Pathology
    • This course provides urologists and allied health professionals an overview of the main pathological characteristics and biology of common neoplasms of the kidney, urinary tract, prostate and testis.
  • Urodynamics
    • This course provides a detailed overview of urodynamic testing techniques and pitfalls including hydrodynamic principles. Emphasis is placed on the interpretation of urodynamics, including recognizing abdominal and detrusor physiologic events, urethral resistance during bladder filling and micturition, urinary incontinence, and recognition of physiologic and technical artifacts.

Target Audience

This activity is designed for:

  • Urology residents
  • Allied Health Professionals

Learning Objectives

After completing this activity, participants will be able to:

  • Pathology
    • Learning Objectives:
      1. Describe the common tumors and their top differential diagnoses in a given GU organ and clinic pathological setting.
      2. Identify the important pathological features, molecular alterations and behavior of common GU tumor entities.
      3. Interpret the latest classification schemes, contemporary grading practices and commonly used ancillary techniques in pathologic diagnosis.
      4. Determine the essential elements in the pathology reporting of common GU tumors and discuss their clinical relevance.       
  • Urodynamics
    • Learning Objectives:
      1. Apply knowledge of lower urinary tract function and electronic measurement of pressure, flow and electromyography to performance of a multichannel urodynamic test including prestudy uroflowmetry, filling cystometrogram and voiding pressure flow study.
Course summary
Available credit: 
  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Non-Physician Participation
Course opens: 
06/08/2018
Course expires: 
06/10/2021
Price:
$50.00
Rating: 
0
 Faculty Disclosures:   
NameCompanyRoleFinancial
Mikel L. Gray, Ph.D.Laborie MedicalMeeting Participant or LecturerYes
3M Inc.Consultant or AdvisorYes
Gladell Paner, MDAmirsys, Inc.Health PublishingYes
    
Education Council Disclosures:
NameCompanyRoleFinancial
Michael R. Abern, MDDepartment of Defense Prostate Cancer Research ProgramScientific Study or TrialYes
 American Urological Association Office of EducationConsultant or AdvisorYes
 Department of Defense Prostate Cancer Research ProgramConsultant or AdvisorYes
Sero Andonian, MDLumenisMeeting Participant or Lecturer, Scientific Study or TrialYes
Timothy Charles Brand, MDNothing to disclose 
Anthony A. Caldamone, MDNothing to disclose 
Matthew S. Christman, MDNothing to disclose 
John D. Denstedt, MDCook UrologyOwner, Product DevelopmentYes
 Endourological SocietyLeadership PositionYes
 Endourological SocietyHealth PublishingYes
Jody DonaldsonNothing to disclose 
Shelby EnglertNothing to disclose 
Allen Gao, MD, PhDPandomedxLeadership Position, Owner, Product DevelopmentYes
Matthew Thomas Gettman, MDCOVR MedicalConsultant or AdvisorYes
 Intuitive SurgicalConsultant or AdvisorYes
 Exact SciencesScientific Study or TrialYes
Howard B. Goldman, MDallerganConsultant or AdvisorYes
 MedtronicConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 CookScientific Study or TrialNo
 NuvectraConsultant or AdvisorYes
 AxonicsConsultant or AdvisorYes
 NewUroConsultant or AdvisorYes
 GalvaniConsultant or AdvisorYes
 bionessScientific Study or TrialNo
William C. Huang, MDPhotocureScientific Study or TrialYes
 Karl StorzScientific Study or TrialYes
 IntuitiveMeeting Participant or LecturerYes
William C. Hulbert, Jr., MDNothing to disclose 
Brant Inman, MD, MS, FRCSCDendreonScientific Study or TrialNo
 Genentech IncScientific Study or TrialNo
 Combat MedicalConsultant or Advisor, Scientific Study or TrialYes
 FKD TherapiesScientific Study or TrialNo
 NucleixScientific Study or TrialYes
 UrogenScientific Study or TrialYes
Mark L. Jordan MD,FACSNothing to disclose 
Martin A. Koyle, MDNothing to disclose 
Yair Lotan, MDabbottScientific Study or TrialNo
 CepheidConsultant or Advisor, Scientific Study or TrialNo
 Pacific EdgeScientific Study or TrialNo
 FKDScientific Study or TrialNo
 MDxHealthConsultant or Advisor, Scientific Study or TrialYes
 biocancellScientific Study or TrialNo
 GenomeDx Biosciences IncScientific Study or TrialNo
 photocureConsultant or Advisor, Scientific Study or TrialNo
Nicole Lara Miller, MDBoston Scientific CorporationConsultant or Advisor, Meeting Participant or LecturerYes
 Practical Reviews In UrologyHealth PublishingYes
Manoj Monga, MD, FACSFortecOtherYes
Ajay Kumar Nangia, MBBS, FACSAUA NewsLeadership Position, Health PublishingYes
NIH CCN TrialScientific Study or TrialYes
Urology Care FoundationLeadership PositionNo
AUA Health Policy CouncilLeadership PositionNo
South Central AUALeadership PositionNo
ASRMLeadership PositionNo
Curtis Nickel, MDFarr LaboratoriesConsultant or AdvisorYes
AquinoxScientific Study or TrialNo
PureTech HealthConsultant or AdvisorYes
AUAHealth PublishingYes
NIHScientific Study or TrialYes
Canadian Institute of Health ResearchScientific Study or TrialYes
Interface BiologicsConsultant or AdvisorYes
Alvio TherapeuticsConsultant or AdvisorYes
Seikagaku CorporationConsultant or AdvisorYes
MedifocusConsultant or AdvisorYes
RedLeaf MedicalConsultant or AdvisorYes
Victor William Nitti, MDAstellasHealth Publishing, Scientific Study or TrialNo
AllerganHealth Publishing, Scientific Study or TrialNo
Serenity PharmeuticalsInvestment InterestYes
MedtronicScientific Study or TrialNo
Christopher Porter, MDNothing to disclose 
Ganesh V. Raj, MD, PhDPtaresOwner, Product DevelopmentYes
 C-diagnostics corpConsultant or Advisor, Investment InterestYes
 amgenMeeting Participant or LecturerYes
 Johnson and JohnsonConsultant or Advisor, Owner, Product DevelopmentYes
 AstellasMeeting Participant or LecturerYes
 ASTELLASConsultant or Advisor, Meeting Participant or LecturerYes
 JanssenOwner, Product DevelopmentYes
 BAYERConsultant or Advisor, Meeting Participant or LecturerYes
 SANOFIConsultant or Advisor, Meeting Participant or LecturerYes
 GaudiumRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes
 MedivationConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 EtiraRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
MDx HealthScientific Study or TrialNo
Lee Richstone, MDNothing to disclose 
Heather SchultzSUNAMeeting Participant or LecturerYes
 SUNALeadership PositionNo
Karl-Dietrich Sievert, MD, PhDMedtronicsMeeting Participant or Lecturer, Scientific Study or TrialYes
 AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 NeotractMeeting Participant or LecturerYes
 StimguardMeeting Participant or Lecturer, Scientific Study or TrialYes
Joseph A. Smith Jr., MDNothing to disclose 
Ryan Patrick Terlecki, MD, FACSAmerican Medical SystemsConsultant or Advisor, OtherYes
 Boston ScientificConsultant or AdvisorYes
 MicroGen DxConsultant or AdvisorYes
 U.S. Department of DefenseScientific Study or TrialYes
Edouard John Trabulsi, MD, FACSGenomeDxConsultant or AdvisorYes
 JanssenConsultant or Advisor, Meeting Participant or LecturerYes
 PfizerConsultant or Advisor, Meeting Participant or LecturerYes
 MerckMeeting Participant or LecturerYes

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Non-Physician Participation

Accreditation Period

Course opens: 
06/08/2018
Course expires: 
06/10/2021

Price

Price:
$50.00
Please login or register to take this course.